|
Age-specific rates, per 100,000 population, by
age-group and serogroup, calendar year, 1995-2003, Northern Ireland
| Serogroup B |
1995 |
1996 |
1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
| 0-2 yrs |
28.7 |
20.6 |
28.9 |
30.4 |
43.1 |
63.1 |
40.3 |
67.2 |
53.8 |
| 3-4 yrs |
5.7 |
9.8 |
6.0 |
10.1 |
6.2 |
20.4 |
18.8 |
8.4 |
18.8 |
| 5-14 yrs |
1.5 |
1.1 |
1.1 |
2.3 |
3.0 |
3.4 |
4.7 |
3.1 |
3.9 |
| 15-17 yrs |
0.0 |
2.5 |
2.5 |
3.8 |
2.6 |
5.1 |
6.2 |
1.2 |
3.7 |
| 18-24 yrs |
1.2 |
0.0 |
0.0 |
0.6 |
0.6 |
6.2 |
0.6 |
3.1 |
4.4 |
| >24 yrs |
0.3 |
0.1 |
0.4 |
0.5 |
0.5 |
0.6 |
0.5 |
0.6 |
0.6 |
| All ages, incl unknown |
2.1 |
1.6 |
2.0 |
2.5 |
3.0 |
4.9 |
3.6 |
4.1 |
4.2 |
| Serogroup C |
1995 |
1996 |
1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
| 0-2 yrs |
6.8 |
4.1 |
6.9 |
6.9 |
18.1 |
11.5 |
0.0 |
0.0 |
0.0 |
| 3-4 yrs |
7.6 |
0.0 |
2.0 |
4.1 |
16.5 |
14.3 |
0.0 |
6.3 |
4.2 |
| 5-14 yrs |
1.1 |
2.6 |
1.9 |
0.8 |
4.2 |
1.9 |
0.4 |
0.0 |
0.4 |
| 15-17 yrs |
2.6 |
0.0 |
2.5 |
3.8 |
0.0 |
5.1 |
0.0 |
0.0 |
0.0 |
| 18-24 yrs |
0.6 |
1.8 |
0.6 |
1.2 |
3.7 |
1.9 |
1.3 |
0.0 |
0.0 |
| >24 yrs |
0.5 |
0.1 |
0.2 |
0.1 |
0.2 |
0.7 |
0.5 |
0.5 |
0.1 |
| All ages, incl unknown |
1.2 |
0.8 |
1.0 |
0.9 |
2.4 |
2.1 |
0.5 |
0.5 |
0.2 |
| All confirmed |
1995 |
1996 |
1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
| 0-2 yrs |
39.6 |
30.2 |
42.7 |
48.4 |
77.8 |
86.0 |
52.3 |
71.7 |
59.8 |
| 3-4 yrs |
13.4 |
13.7 |
12.0 |
20.3 |
28.9 |
38.8 |
20.9 |
14.6 |
23.0 |
| 5-14 yrs |
2.6 |
4.5 |
4.1 |
3.4 |
7.6 |
6.1 |
5.1 |
3.5 |
4.7 |
| 15-17 yrs |
2.6 |
5.0 |
7.5 |
7.6 |
2.6 |
12.7 |
9.9 |
1.2 |
3.7 |
| 18-24 yrs |
2.3 |
2.4 |
1.2 |
2.4 |
4.9 |
8.7 |
1.9 |
3.8 |
5.0 |
| >24 yrs |
0.8 |
0.2 |
0.8 |
0.8 |
0.7 |
1.4 |
1.0 |
1.1 |
0.8 |
| All ages, incl unknown |
3.6 |
3.2 |
3.9 |
4.3 |
6.3 |
8.0 |
4.8 |
4.9 |
4.9 |
Enhanced Surveillance of Meningococcal Disease
Rates, per 100,000 population, all ages, by serogroup
and calendar year, 1995-2003*, Northern Ireland
| |
B |
C |
W135 |
Others |
All confirmed |
Unconfirmed |
Total (confirmed and probable) |
| 1995 |
2.1 |
1.2 |
0.1 |
0.1 |
3.6 |
0.0 |
3.6 |
| 1996 |
1.6 |
0.8 |
0.1 |
0.7 |
3.2 |
0.0 |
3.2 |
| 1997 |
2.0 |
1.0 |
0.2 |
0.8 |
3.9 |
0.0 |
3.9 |
| 1998 |
2.5 |
0.9 |
0.1 |
0.8 |
4.3 |
0.0 |
4.3 |
| 1999 |
3.0 |
2.4 |
0.1 |
0.9 |
6.3 |
4.5 |
10.8 |
| 2000 |
4.9 |
2.1 |
0.2 |
0.8 |
8.0 |
4.2 |
12.3 |
| 2001 |
3.6 |
0.5 |
0.1 |
0.6 |
4.8 |
3.0 |
7.8 |
| 2002 |
4.1 |
0.5 |
0.0 |
0.3 |
4.9 |
3.0 |
7.9 |
| 2003 |
4.2 |
0.2 |
0.0 |
0.5 |
4.9 |
2.0 |
6.9 |
Data from 1995-1998 are based on laboratory reports of N. meningitidis.
Data from 1999-2003 are based on enhanced surveillance of meningococcal
disease notifications validated with laboratory reports
|